Comparative Clinical Utility of Tumor Genomic Testing and Cell-Free DNA in Metastatic Breast Cancer

摘要

PurposeBreast cancer metastases differ biologically from primary disease; therefore, metastatic biopsies may assist in treatment decision-making. Commercial genomic testing of both tumor and circulating tumor DNA have become available clinically, but utility of these tests in breast cancer management remains unclear.